Estée Lauder

Estée Lauder has partnered with biotech and pharmaceutical company Serpin Pharma to explore groundbreaking ingredient innovations.

Serpin Pharma has been researching anti-inflammatory technologies for over 20 years, and Estée Lauder will now examine their potential applications in cosmetics. This collaboration aligns with Estée Lauder’s "Beauty Reimagined" strategy, which focuses on bringing cutting-edge scientific advancements to the beauty industry.

Carl Haney, Executive Vice President of Global Innovation, Research & Development at Estée Lauder, commented: "This new technology will advance our transformative innovation program, pushing the boundaries of cutting-edge scientific discoveries."

Cohava Gelber, Founder, Executive Chair, and CEO of Serpin Pharma, added: "Serpin Pharma is built on the principles of biomimicry and understanding how nature resolves injuries and damage. We take a novel approach by leveraging the body’s innate mechanisms for inflammation resolution."